Barra F, Ferro Desideri L, Ferrero S. Transforming growth factor β (TGF-β): is there a different role with regard to distinct phenotypes of endometriosis? Immunol Lett 2019;211:1-2. https://www.sciencedirect.com/science/article/abs/pii/S016524781930077X?via%3Dihub
Elagolix sodium for the treatment of women with moderate to severe endometriosis-associated pain
Barra F, Scala C, Ferrero S. Elagolix sodium for the treatment of women with moderate to severe endometriosis-associated pain. Drugs Today 2019;55:237-246. https://journals.prous.com/journals/servlet/xmlxsl/pk_journals.xml_summaryn_pr?p_JournalId=4&p_RefId=2930713
Nintedanib for Advanced Epithelial Ovarian Cancer: A Change of Perspective? Summary of Evidence from a Systematic Review
Barra F, Laganà AS, Ghezzi F, Casarin J, Ferrero S. Nintedanib for Advanced Epithelial Ovarian Cancer: A Change of Perspective? Summary of Evidence from a Systematic Review. Gynecol Obstet Invest 2019;84:107-117. https://www.karger.com/Article/FullText/493361
Prof. Simone Ferrero è entrato a far parte dell’Editorial Board della rivista Archives in Obstetrics and Gynecology
Prof. Simone Ferrero è entrato a far parte dell’Editorial Board della rivista Archives in Obstetrics and Gynecology https://www.springer.com/journal/404
Efficacy and fertility outcomes of levonorgestrel-releasing intra-uterine system treatment for patients with atypical complex hyperplasia or endometrial cancer: a retrospective study
Leone Roberti Maggiore U, Martinelli F, Dondi G, Bogani G, Chiappa V, Evangelista MT, Liberale V, Ditto A, Ferrero S, Raspagliesi F. Efficacy and fertility outcomes of levonorgestrel-releasing intra-uterine system treatment for patients with atypical complex hyperplasia or endometrial cancer: a retrospective study. J Gynecol Oncol 2019;30:e57. https://www.ejgo.org/DOIx.php?id=10.3802/jgo.2019.30.e57
Estradiol in non-oral hormonal contraception: a “long and winding road”
Grandi G, Barra F, Ferrero S, Facchinetti F. Estradiol in non-oral hormonal contraception: a “long and winding road”. Expert Rev Endocrinol Metab 201);14:153-155. https://www.tandfonline.com/doi/full/10.1080/17446651.2019.1604217
A comprehensive review of hormonal and biological therapies for endometriosis: latest developments
Barra F, Grandi G, Tantari M, Scala C, Facchinetti F, Ferrero S. A comprehensive review of hormonal and biological therapies for endometriosis: latest developments. Expert Opin Biol Ther 2019;19:343-360. https://www.tandfonline.com/doi/abs/10.1080/14712598.2019.1581761?journalCode=iebt20
Predictive factors of recurrence in patients with early‐stage epithelial ovarian cancer
Ditto A, Leone Roberti Maggiore U, Bogani G, Martinelli F, Chiappa V, Evangelista MT, Liberale V, Ferrero S, Raspagliesi F. Predictive factors of recurrence in patients with early-stage epithelial ovarian cancer. Int J Gynaecol Obstet 2019;145:28-33. https://obgyn.onlinelibrary.wiley.com/doi/abs/10.1002/ijgo.12769
The role of monocytic myeloid‐derived suppressor cells in the pathogenesis of endometriosis
Barra F, Ferrero S. The role of monocytic myeloid-derived suppressor cells in the pathogenesis of endometriosis. Am J Reprod Immunol 2019;81:e13094. https://onlinelibrary.wiley.com/doi/abs/10.1111/aji.13094
Il Prof. Simone Ferrero è l’Editor in Chief del World Journal of Obstetrics and Gynecology
Il Prof. Simone Ferrero è l’Editor in Chief del World Journal of Obstetrics and Gynecology https://www.wjgnet.com/2218-6220 )